EventsThe 2nd International Conference on Bioengineering
Published
This submission belongs to the session S4. Biomedical Engineering and Biomaterials of the event The 2nd International Conference on Bioengineering
Published date
16 Nov, 2026
Citation
Shambhavi Pandey, Benjami Oller Salvia, Protease-Activated Lipid Nanoparticles Enable Tumor-Selective Transfection through Reversible Surface Masking, in Proceedings of The 2nd International Conference on Bioengineering, Barcelona, 10 November–13 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Protease-Activated Lipid Nanoparticles Enable Tumor-Selective Transfection through Reversible Surface Masking

1. Department of Bioengineering, Institut Químic de Sarrià (IQS), Universitat Ramon Llull, Barcelona, Spain (08017)
Abstract

Lipid nanoparticles (LNPs) exhibit significant potential for targeted cancer therapy; however, their constitutive transfection activity can result in non-specific off-target delivery. To overcome this limitation, we engineered a conditionally active LNP platform that remains functionally masked during circulation and is selectively activated within the protease-rich tumor microenvironment (TME).

The LNPs were surface-engineered by conjugating a protease-cleavable zwitterionic peptide to the polyethylene glycol (PEG) component through thiol-maleimide chemistry. The zwitterionic peptide masks cellular uptake and transfection, while proteolytic cleavage within the TME removes the masking layer, restoring LNP activity. The engineered LNPs were characterized for particle size, polydispersity index (PDI), zeta potential, masking efficiency, and protease-triggered recovery of transfection. Functional performance was further evaluated using in situ transfection assays in protease-positive and protease-negative cancer cell lines.

The conditionally active LNPs exhibited hydrodynamic diameters of 100-180 nm, PDI < 0.2, and near-neutral surface charge (±5 mV), demonstrating suitable physicochemical properties for systemic delivery. The zwitterionic masking strategy reduced transfection efficiency by approximately 75% under non-activating conditions. Following protease-mediated cleavage, transfection activity was restored by up to 97% in vitro. Furthermore, in situ studies demonstrated significantly enhanced transfection in protease-positive cells compared with protease-negative controls, confirming selective protease-dependent activation of our masked system.

These findings demonstrate that protease-responsive masking enables conditional activation of LNPs, substantially improving tumor-selective transfection while minimizing off-target delivery. This modular and broadly adaptable strategy represents a promising platform for the targeted delivery of nucleic acids and other therapeutics to solid tumors, with broad potential to improve the safety and efficacy of LNP-based cancer therapies.

Keywords
LNP
conditional activation
zwitterionic
peptide
thiol-maleimide conjugation
masking
Hierarchical Machine Learning of Salivary SERS Fingerprints for Noninvasive Discrimination of TMD, OLP, and BMS
Machine Learning vs Traditional Risk Scores for Predicting 30-Day In-Hospital Mortality in Upper Gastrointestinal Bleeding